Search - tctmd.com

Displaying 301 - 320 of 521

Sort: Relevancy | Date

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Daily News

CMS Lauded for Coverage Decision on Supervised Exercise Therapy for PAD

L.A. McKeown

June 08, 2017

News Daily News

Growing Gap in CVD Risk Factor Control Between Rich and Poor

Michael O'Riordan

June 08, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Daily News

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

Todd Neale

June 05, 2017

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Shelley Wood

June 05, 2017

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Daily News

Color-Coded Radiation Monitoring: Coming to a Cath Lab Near You

L.A. McKeown

June 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Daily News

Lowering of Systolic BP Beyond Current Targets Gets Boost in New Analysis

Michael O'Riordan

May 31, 2017

News Daily News

Anticoagulation in Pregnant Women With Mechanical Heart Valves: A Balancing Act

Caitlin E. Cox

May 31, 2017

News Daily News

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Michael O'Riordan

May 30, 2017

News Daily News

Statins Provide No Benefit in Older Adults Without CVD: ALLHAT Analysis

Michael O'Riordan

May 29, 2017

News Daily News

Therapies Aimed at New Genetic Target Show Early Promise for Lowering Triglycerides

Todd Neale

May 26, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Daily News

Cardiovascular Disease Is a Major Worldwide Threat to Public Health, Global Analysis Finds

Alison Palkhivala

May 25, 2017

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

Advertisement

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

CMS Lauded for Coverage Decision on Supervised Exercise Therapy for PAD

Growing Gap in CVD Risk Factor Control Between Rich and Poor

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Color-Coded Radiation Monitoring: Coming to a Cath Lab Near You

TCTMD’s Top 10 Most Popular Stories for May 2017

Lowering of Systolic BP Beyond Current Targets Gets Boost in New Analysis

Anticoagulation in Pregnant Women With Mechanical Heart Valves: A Balancing Act

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Statins Provide No Benefit in Older Adults Without CVD: ALLHAT Analysis

Therapies Aimed at New Genetic Target Show Early Promise for Lowering Triglycerides

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Cardiovascular Disease Is a Major Worldwide Threat to Public Health, Global Analysis Finds

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content